News for Option Care Health, Inc. (OPCH)

Option Care (OPCH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Revenue Growth: 19.7% increase over Q4 2023.Gross Profit Growth: 8.6% growth over the prior year fourth quarter.SGNA as Percentage of Revenue: 12.2% in the qua

Feb 26, 2025 / 01:30PM GMTOperator Good day and thank you for standing by. Welcome to the Option Care Health fourth quarter 2024 earnings conference call. At th

Call Start: 8:30 January 1, 0000 9:19 AM ETOption Care Health, Inc.

Quarterly Revenue: Achieved $1,346.4 million, surpassing the estimated $1,289.45 million, marking a 19.7% increase from the previous year.Quarterly EPS: Report

Option Care Health Inc (OPCH), the largest independent provider of home and alternate site infusion services in the U.S., released its financial results for the

BANNOCKBURN, Ill., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the ”œCompany” or ”œOption Care Health”) ( OPCH), the nation's largest in

Transaction Overview On December 31, 2024, Park West Asset Management LLC (Trades, Portfolio) made a strategic decision to reduce its holdings in LENSAR Inc (NA

Significant Transaction by Park West Asset Management LLC (Trades, Portfolio) On December 31, 2024, Park West Asset Management LLC (Trades, Portfolio) executed

U.S. stock futures were higher this morning, with the Dow Jones futures gaining around 150 points on Monday. Shares of Tesla, Inc TSLA fell in today's pre-mark...

We recently compiled a list of the 12 Best Booming Stocks to Invest in Now. In this article, we are going to take a look at where Option Care Health, Inc.

Jefferies has upgraded Option Care Health (OPCH) to buy from hold, citing removal of an overhang related to pricing adjustments for the drug Stelara. Read more here.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

Option Care gets 75% of its revenues from chronic therapies and 25% from acute treatments, but its growth now looks relatively limited. Read my OPCH stock analysis.

Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare have been highlighted in this Industry Outlook article.

On January 13, 2025, Option Care Health Inc (OPCH), the largest independent provider of home and alternate site infusion services in the U.S., released its prel

BANNOCKBURN, Ill., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the ”œCompany” or ”œOption Care Health”) ( OPCH), the nation's largest in

Shares of Option Care Health Inc (OPCH) surged 3.83% in mid-day trading on Jan 4. The stock reached an intraday high of $23.64, before settling at $23.57, u

Shares of Option Care Health Inc (OPCH) fell 3.73% in mid-day trading on Dec 5. The stock reached an intraday low of $22.68, before recovering slightly to $22